- $1.37bn
- $1.35bn
- $541.32m
Annual cashflow statement for CTS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -41.9 | 59.6 | 60.5 | 58.1 | 65.3 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 139 | 9.77 | 7.15 | 5.7 | -1.03 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.66 | 21.6 | -3.54 | 7.35 | 3.69 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 86.1 | 121 | 88.8 | 99.3 | 102 |
| Capital Expenditures | -15.6 | -14.3 | -14.7 | -18.6 | -15.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.255 | -96.9 | -3.36 | -122 | -2.78 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -15.9 | -111 | -18.1 | -141 | -18.5 |
| Financing Cash Flow Items | -2.15 | -2.72 | -3.26 | -4.21 | -2.71 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -20.7 | 4.34 | -65.4 | -27.9 | -98.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 49.7 | 15.4 | 6.97 | -69.5 | -12 |